Reaction

Motion Sickness reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,891 reports · 39 co-occurring drugs

As of the last recalculation, Motion Sickness appears in 1,891 FAERS reports alongside 39 co-occurring drug terms. The strongest observed disproportionality signal is CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES (PRR 20.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Calcium, Magnesium, Potassium, And Sodium Oxybates	16	20.6	20.7
Naltrexone Hydrochloride And Bupropion Hydrochloride	11	14.3	14.3
Meclizine Hydrochloride	23	13.1	13.1
Trimethoprim	12	11.3	11.3
Rizatriptan Benzoate	10	10.9	10.9
Sodium Oxybate	58	10.0	10.0
Niraparib	18	9.0	9.0
Armodafinil	17	8.9	9.0
Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate And Amphetamine Aspartate	33	8.9	8.9
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate	28	8.8	8.9
Rucaparib	7	8.8	8.8
Erlotinib	7	8.0	8.0
Atomoxetine Hydrochloride	16	7.5	7.5
Buspirone Hydrochloride	7	7.0	7.0
Modafinil	19	6.5	6.5
Nintedanib	18	6.4	6.4
Erlotinib Hydrochloride	7	6.2	6.2
Ofatumumab	17	5.7	5.7
Esketamine Hydrochloride	9	5.6	5.6
Avapritinib	6	5.5	5.5
Desvenlafaxine Succinate	13	5.3	5.3
Abaloparatide	14	5.3	5.3
Rimegepant Sulfate	6	5.2	5.2
Fremanezumab-Vfrm	5	4.8	4.8
Fingolimod Hcl	36	4.7	4.7
Diroximel Fumarate	5	4.6	4.6
Loratadine And Pseudoephedrine Sulfate	3	4.2	4.2
Naltrexone	11	3.9	3.9
Teriflunomide	14	3.4	3.4
Natalizumab	55	3.4	3.4
Exenatide	16	3.4	3.4
Peginterferon Beta-1A	4	3.4	3.4
Dimethyl Fumarate	37	3.4	3.4
Elexacaftor, Tezacaftor, And Ivacaftor	3	2.7	2.7
Drospirenone And Ethinyl Estradiol	10	2.5	2.5
Tirzepatide	22	1.5	1.5
Apremilast	19	1.4	1.4
Etonogestrel	6	1.4	1.4
Levonorgestrel	23	1.3	1.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.